Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2012

01-04-2012 | Review

Antioxidants and Chronic Pancreatitis: Theory of Oxidative Stress and Trials of Antioxidant Therapy

Authors: Brianna Grigsby, Horacio Rodriguez-Rilo, Khalid Khan

Published in: Digestive Diseases and Sciences | Issue 4/2012

Login to get access

Abstract

Chronic pancreatitis (CP) is an inflammatory disease characterized by the progressive destruction of pancreatic tissue and resulting in pancreatic exocrine and endocrine insufficiency. Increased oxidative stress has been implicated as a potential mechanism in its etiology and pathology. A number of studies have demonstrated that CP patients have a compromised antioxidant status, which may be a contributing factor to the enhanced oxidative state associated with the disease. Nutrition is an essential consideration in the treatment of CP, especially since diet is a source of several antioxidants and cofactors required for the production of cellular antioxidant enzymes. Many CP patients have an inadequate intake of macro and micronutrients because of abdominal pain and discomfort, which often increase postprandially and discourage eating. Exocrine insufficiency leads to further complications by preventing adequate digestion and absorption of ingested food, thus causing even greater deficiencies and impairment of antioxidant status. The aims of this article are to review the oxidative stress model of CP and to examine the evidence for nutrition, and, particularly, antioxidants, in the treatment of CP.
Literature
1.
go back to reference Tasci I, Deveci S, Isik AT, et al. Allopurinol in rat chronic pancreatitis: effects on pancreatic stellate cell activation. Pancreas. 2007;35:366–371.PubMedCrossRef Tasci I, Deveci S, Isik AT, et al. Allopurinol in rat chronic pancreatitis: effects on pancreatic stellate cell activation. Pancreas. 2007;35:366–371.PubMedCrossRef
2.
go back to reference Vardanyan M, Rilo HL. Pathogenesis of chronic pancreatitis-induced pain. Discov Med. 2010;9:304–310.PubMed Vardanyan M, Rilo HL. Pathogenesis of chronic pancreatitis-induced pain. Discov Med. 2010;9:304–310.PubMed
3.
go back to reference Andrén-Sandberg A, Hoem D, Gislason H. Pain management in chronic pancreatitis. Eur J Gastroenterol Hepatol. 2002;14:957–970.PubMedCrossRef Andrén-Sandberg A, Hoem D, Gislason H. Pain management in chronic pancreatitis. Eur J Gastroenterol Hepatol. 2002;14:957–970.PubMedCrossRef
4.
go back to reference Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682–707.PubMedCrossRef Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682–707.PubMedCrossRef
5.
go back to reference Keller J, Layer P. Idiopathic chronic pancreatitis. Best Pract Res Clin Gastroenterol. 2008;22:105–113.PubMedCrossRef Keller J, Layer P. Idiopathic chronic pancreatitis. Best Pract Res Clin Gastroenterol. 2008;22:105–113.PubMedCrossRef
6.
go back to reference Bachmann K, Izbicki JR, Yekebas EF. Chronic pancreatitis: modern surgical management. Langenbecks Arch Surg. 2011;396:139–149.PubMedCrossRef Bachmann K, Izbicki JR, Yekebas EF. Chronic pancreatitis: modern surgical management. Langenbecks Arch Surg. 2011;396:139–149.PubMedCrossRef
7.
go back to reference Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993;328:1433–1437.PubMedCrossRef Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993;328:1433–1437.PubMedCrossRef
8.
go back to reference Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci. 1983;28:97–102.PubMedCrossRef Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci. 1983;28:97–102.PubMedCrossRef
9.
go back to reference Slaff J, Jacobson D, Tillman CR, Curington C, Toskes P. Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology. 1984;87:44–52.PubMed Slaff J, Jacobson D, Tillman CR, Curington C, Toskes P. Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology. 1984;87:44–52.PubMed
10.
go back to reference Costamagna G, Bulajic M, Tringali A, et al. Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy. 2006;38:254–259.PubMedCrossRef Costamagna G, Bulajic M, Tringali A, et al. Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy. 2006;38:254–259.PubMedCrossRef
11.
go back to reference Fink AS, Perez de Ayala V, Chapman M, Cotton PB. Radiologic pitfalls in endoscopic retrograde pancreatography. Pancreas. 1986;1:180–187.PubMedCrossRef Fink AS, Perez de Ayala V, Chapman M, Cotton PB. Radiologic pitfalls in endoscopic retrograde pancreatography. Pancreas. 1986;1:180–187.PubMedCrossRef
12.
go back to reference Tessier G, Bories E, Arvanitakis M, et al. EUS-guided pancreatogastrostomy and pancreatobulbostomy for the treatment of pain in patients with pancreatic ductal dilatation inaccessible for transpapillary endoscopic therapy. Gastrointest Endosc. 2007;65:233–241.PubMedCrossRef Tessier G, Bories E, Arvanitakis M, et al. EUS-guided pancreatogastrostomy and pancreatobulbostomy for the treatment of pain in patients with pancreatic ductal dilatation inaccessible for transpapillary endoscopic therapy. Gastrointest Endosc. 2007;65:233–241.PubMedCrossRef
13.
go back to reference Kahaleh M, Hernandez AJ, Tokar J, Adams RB, Shami VM, Yeaton P. EUS-guided pancreaticogastrostomy: analysis of its efficacy to drain inaccessible pancreatic ducts. Gastrointest Endosc. 2007;65:224–230.PubMedCrossRef Kahaleh M, Hernandez AJ, Tokar J, Adams RB, Shami VM, Yeaton P. EUS-guided pancreaticogastrostomy: analysis of its efficacy to drain inaccessible pancreatic ducts. Gastrointest Endosc. 2007;65:224–230.PubMedCrossRef
14.
go back to reference Ergun M, Aouattah T, Gillain C, Gigot JF, Hubert C, Deprez PH. Endoscopic ultrasound-guided transluminal drainage of pancreatic duct obstruction: long-term outcome. Endoscopy. 2011;43:518–525.PubMedCrossRef Ergun M, Aouattah T, Gillain C, Gigot JF, Hubert C, Deprez PH. Endoscopic ultrasound-guided transluminal drainage of pancreatic duct obstruction: long-term outcome. Endoscopy. 2011;43:518–525.PubMedCrossRef
15.
go back to reference Rodriguez Rilo HL, Ahmad SA, D’Alessio D, et al. Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg. 2003;7:978–989.PubMedCrossRef Rodriguez Rilo HL, Ahmad SA, D’Alessio D, et al. Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg. 2003;7:978–989.PubMedCrossRef
16.
17.
go back to reference Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci. 2011;120:S49–S75.PubMedCrossRef Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci. 2011;120:S49–S75.PubMedCrossRef
18.
go back to reference Stenson WF, Lobos E, Wedner HJ. Glutathione depletion inhibits amylase release in guinea pig pancreatic acini. Am J Physiol. 1983;244:G273–G277.PubMed Stenson WF, Lobos E, Wedner HJ. Glutathione depletion inhibits amylase release in guinea pig pancreatic acini. Am J Physiol. 1983;244:G273–G277.PubMed
19.
go back to reference Ohashi S, Nishio A, Nakamura H, et al. Overexpression of redox-active protein thioredoxin-1 prevents development of chronic pancreatitis in mice. Antioxid Redox Signal. 2006;8:1835–1845.PubMedCrossRef Ohashi S, Nishio A, Nakamura H, et al. Overexpression of redox-active protein thioredoxin-1 prevents development of chronic pancreatitis in mice. Antioxid Redox Signal. 2006;8:1835–1845.PubMedCrossRef
20.
go back to reference Zeki S, Miura S, Suzuki H, et al. Xanthine oxidase-derived oxygen radicals play significant roles in the development of chronic pancreatitis in WBN/Kob rats. J Gastroenterol Hepatol. 2002;17:606–616.PubMedCrossRef Zeki S, Miura S, Suzuki H, et al. Xanthine oxidase-derived oxygen radicals play significant roles in the development of chronic pancreatitis in WBN/Kob rats. J Gastroenterol Hepatol. 2002;17:606–616.PubMedCrossRef
21.
go back to reference Verlaan M, Roelofs HM, van-Schaik A, et al. Assessment of oxidative stress in chronic pancreatitis patients. World J Gastroenterol. 2006;12:5705–5710.PubMed Verlaan M, Roelofs HM, van-Schaik A, et al. Assessment of oxidative stress in chronic pancreatitis patients. World J Gastroenterol. 2006;12:5705–5710.PubMed
22.
go back to reference Morris-Stiff GJ, Bowrey DJ, Oleesky D, Davies M, Clark GW, Puntis MC. The antioxidant profiles of patients with recurrent acute and chronic pancreatitis. Am J Gastroenterol. 1999;94:2135–2140.PubMedCrossRef Morris-Stiff GJ, Bowrey DJ, Oleesky D, Davies M, Clark GW, Puntis MC. The antioxidant profiles of patients with recurrent acute and chronic pancreatitis. Am J Gastroenterol. 1999;94:2135–2140.PubMedCrossRef
23.
go back to reference Quilliot D, Walters E, Bonte JP, Fruchart JC, Duriez P, Ziegler O. Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis. Am J Clin Nutr. 2005;81:1117–1125.PubMed Quilliot D, Walters E, Bonte JP, Fruchart JC, Duriez P, Ziegler O. Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis. Am J Clin Nutr. 2005;81:1117–1125.PubMed
24.
go back to reference Girish BN, Rajesh G, Vaidyanathan K, Balakrishnan V. Assessment of oxidative status in chronic pancreatitis and its relation with zinc status. Indian J Gastroenterol. 2011;30:84–88.PubMedCrossRef Girish BN, Rajesh G, Vaidyanathan K, Balakrishnan V. Assessment of oxidative status in chronic pancreatitis and its relation with zinc status. Indian J Gastroenterol. 2011;30:84–88.PubMedCrossRef
25.
go back to reference O’Keane M, Moore MR, Goldberg A. Elevation of alcohol dehydrogenase activity in the subclinically scorbutic guinea-pig. Clin Sci. 1972;42:781–784.PubMed O’Keane M, Moore MR, Goldberg A. Elevation of alcohol dehydrogenase activity in the subclinically scorbutic guinea-pig. Clin Sci. 1972;42:781–784.PubMed
26.
go back to reference Schoenberg MH, Büchler M, Pietrzyk C, et al. Lipid peroxidation and glutathione metabolism in chronic pancreatitis. Pancreas. 1995;10:36–43.PubMedCrossRef Schoenberg MH, Büchler M, Pietrzyk C, et al. Lipid peroxidation and glutathione metabolism in chronic pancreatitis. Pancreas. 1995;10:36–43.PubMedCrossRef
27.
go back to reference Santini SA, Spada C, Bononi F, et al. Liver, pancreas and biliary tract enhanced lipoperoxidation products in pure pancreatic juice: evidence for organ-specific oxidative stress in chronic pancreatitis. Dig Liver Dis. 2003;35:888–892.PubMedCrossRef Santini SA, Spada C, Bononi F, et al. Liver, pancreas and biliary tract enhanced lipoperoxidation products in pure pancreatic juice: evidence for organ-specific oxidative stress in chronic pancreatitis. Dig Liver Dis. 2003;35:888–892.PubMedCrossRef
28.
go back to reference Salim AS. Role of oxygen-derived free radical scavengers in the treatment of recurrent pain produced by chronic pancreatitis. A new approach. Arch Surg. 1991;126:1109–1114.PubMedCrossRef Salim AS. Role of oxygen-derived free radical scavengers in the treatment of recurrent pain produced by chronic pancreatitis. A new approach. Arch Surg. 1991;126:1109–1114.PubMedCrossRef
29.
go back to reference Banks PA, Hughes M, Ferrante M, Noordhoek EC, Ramagopal V, Slivka A. Does allopurinol reduce pain of chronic pancreatitis? Int J Pancreatol. 1997;22:171–176.PubMed Banks PA, Hughes M, Ferrante M, Noordhoek EC, Ramagopal V, Slivka A. Does allopurinol reduce pain of chronic pancreatitis? Int J Pancreatol. 1997;22:171–176.PubMed
30.
go back to reference Braganza JM, Bilton D, Schofield D, Mei G, Kay PM, Bottiglieri T. Placebo-controlled trials of antioxidant therapy including S-adenosylmethionine in patients with recurrent nongallstone pancreatitis. Drug Investig. 1994;8:10–20. Braganza JM, Bilton D, Schofield D, Mei G, Kay PM, Bottiglieri T. Placebo-controlled trials of antioxidant therapy including S-adenosylmethionine in patients with recurrent nongallstone pancreatitis. Drug Investig. 1994;8:10–20.
31.
go back to reference Uden S, Bilton D, Nathan L, Hunt LP, Main C, Braganza JM. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther. 1990;4:357–371.PubMedCrossRef Uden S, Bilton D, Nathan L, Hunt LP, Main C, Braganza JM. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther. 1990;4:357–371.PubMedCrossRef
32.
go back to reference Uden S, Schofield D, Miller PF, Day JP, Bottiglier T, Braganza JM. Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther. 1992;6:229–240.PubMedCrossRef Uden S, Schofield D, Miller PF, Day JP, Bottiglier T, Braganza JM. Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther. 1992;6:229–240.PubMedCrossRef
33.
go back to reference Amoli MM, Mousavizadeh R, Sorouri R, Rahmani M, Larijani B. Curcumin inhibits in vitro MCP-1 release from mouse pancreatic islets. Transplant Proc. 2006;38:3035–3038.PubMedCrossRef Amoli MM, Mousavizadeh R, Sorouri R, Rahmani M, Larijani B. Curcumin inhibits in vitro MCP-1 release from mouse pancreatic islets. Transplant Proc. 2006;38:3035–3038.PubMedCrossRef
34.
go back to reference Durgaprasad S, Pai CG, Vasanthkumar, Alvres JF, Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res. 2005;122:315–318.PubMed Durgaprasad S, Pai CG, Vasanthkumar, Alvres JF, Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res. 2005;122:315–318.PubMed
35.
go back to reference Banerjee B, Bagchi D. Beneficial effects of a novel IH636 grape seed proanthocyanidin extract in the treatment of chronic pancreatitis. Digestion. 2001;63:203–206.PubMedCrossRef Banerjee B, Bagchi D. Beneficial effects of a novel IH636 grape seed proanthocyanidin extract in the treatment of chronic pancreatitis. Digestion. 2001;63:203–206.PubMedCrossRef
36.
go back to reference Kirk GR, White JS, McKie L, et al. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastrointest Surg. 2006;10:499–503.PubMedCrossRef Kirk GR, White JS, McKie L, et al. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastrointest Surg. 2006;10:499–503.PubMedCrossRef
37.
go back to reference Bhardwaj P, Garg PK, Maulik SK, Saraya A, Tandon RK, Acharya SK. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009;136:149–159 e2.PubMedCrossRef Bhardwaj P, Garg PK, Maulik SK, Saraya A, Tandon RK, Acharya SK. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009;136:149–159 e2.PubMedCrossRef
38.
go back to reference Shah NS, Makin AJ, Sheen AJ, Siriwardena AK. Quality of life assessment in patients with chronic pancreatitis receiving antioxidant therapy. World J Gastroenterol. 2010;16:4066–4071.PubMedCrossRef Shah NS, Makin AJ, Sheen AJ, Siriwardena AK. Quality of life assessment in patients with chronic pancreatitis receiving antioxidant therapy. World J Gastroenterol. 2010;16:4066–4071.PubMedCrossRef
Metadata
Title
Antioxidants and Chronic Pancreatitis: Theory of Oxidative Stress and Trials of Antioxidant Therapy
Authors
Brianna Grigsby
Horacio Rodriguez-Rilo
Khalid Khan
Publication date
01-04-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2037-3

Other articles of this Issue 4/2012

Digestive Diseases and Sciences 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.